The estimated Net Worth of James Edeerfield Management... is at least 29.8 百万$ dollars as of 24 January 2020. James Management owns over 639,506 units of Homology Medicines Inc stock worth over 482,509$ and over the last 7 years James sold FIXX stock worth over 29,320,046$.
James has made over 6 trades of the Homology Medicines Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently James sold 518,827 units of FIXX stock worth 8,015,877$ on 29 January 2020.
The largest trade James's ever made was buying 1,250,000 units of Homology Medicines Inc stock on 2 April 2018 worth over 20,000,000$. On average, James trades about 576,066 units every 111 days since 2018. As of 24 January 2020 James still owns at least 518,827 units of Homology Medicines Inc stock.
You can see the complete history of James Management stock trades at the bottom of the page.
Over the last 7 years, insiders at Homology Medicines Inc have traded over 108,214,465$ worth of Homology Medicines Inc stock and bought 3,033,333 units worth 51,999,993$ . The most active insiders traders include Steven Gillis、James Edeerfield Management...、Kush Parmar. On average, Homology Medicines Inc executives and independent directors trade stock every 26 days with the average trade being worth of 106,785$. The most recent stock trade was executed by Paul Alloway on 25 March 2024, trading 23,530 units of FIXX stock currently worth 21,883$.
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Homology Medicines Inc executives and other stock owners filed with the SEC include: